Press Releases
DMC Biotechnologies secures a place in the 2019 Global Cleantech 100
15 March 2021 – DMC Biotechnologies has successfully demonstrated full commercial scale (85m3 fermentation at EW Biotech, Germany) for its first product, the amino acid L-alanine. The scale-up results identically tracked the…
DMC Biotechnologies, Inc. Announces that Breakthrough Energy Ventures (BEV) has joined Capricorn Venture Partners in participating in their Series Seed Round
15 March 2021 – DMC Biotechnologies has successfully demonstrated full commercial scale (85m3 fermentation at EW Biotech, Germany) for its first product, the amino acid L-alanine. The scale-up results identically tracked the…
DMC Announces Appointment of Carolyn Fritz to Board of Directors
15 March 2021 – DMC Biotechnologies has successfully demonstrated full commercial scale (85m3 fermentation at EW Biotech, Germany) for its first product, the amino acid L-alanine. The scale-up results identically tracked the…
DMC Biotechnologies, Inc. Announces First Close of $1.75M Equity Financing Led by Leuven (Belgium) based Capricorn Venture Partners
09 January 2018 – DMC (www.dmcbio.com), an early-stage biotechnology company, announced today that is has raised a first equity financing led by Capricorn Venture Partners. The company also announced the addition to its Board of Directors of Rob van der Meij,...